Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Charlotte, North Carolina 28210


Purpose:

The purpose of this phase III study is to determine the safety and efficacy of difluprednate in the management of inflammation following ocular surgery.


Criteria:

Inclusion Criteria: - Scheduled for unilateral ocular surgery. Exclusion Criteria: - Systemic administration of any corticosteroid or immunosuppressive drug in the 2 weeks prior to study enrollment.


NCT ID:

NCT00616070


Primary Contact:

Study Chair
Roger Vogel, MD
Sirion Therapeutics


Backup Contact:

N/A


Location Contact:

Charlotte, North Carolina 28210
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 22, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.